Study on Prediction of Left Ventricular Remodeling Using ST2
NCT ID: NCT03841214
Last Updated: 2022-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
114 participants
OBSERVATIONAL
2019-02-25
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incheon-Bucheon Cohort of Patients Undergoing Primary PCI for Acute STEMI
NCT02804958
Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction
NCT03238508
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
NCT02792075
Association Between IVUS and OCT Parameters and Invasive Physiologic Indices
NCT03795714
Prognostic Implications of Physiologic Investigation After Revascularization With Stent
NCT04684043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ACS(Acute Coronary Syndrome) patients with LV systolic dysfunction(LVEF\<50%) on TTE test who underwent successful PCI. At that time, patient proceed with the Baseline blood test(ST2) in hospital.
And then, Medical therapy for 3 months later patient proceed with the Follow-up blood test(ST2) and TTE in OPD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with acute coronary syndrome who underwent successful percutaneous coronary intervention
* Patients with left ventricular ejection fraction less than 50% on transthoracic echocardiography
* Patients who voluntarily agreed to participate in the study
Exclusion Criteria
* If the remaining life span is less than one year
* Women who are breastfeeding or plan to become pregnant or are planning to become pregnant during the study period
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keimyung University Dongsan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kim Hyungseop
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyung-Seop Kim, Postdoctoral
Role: PRINCIPAL_INVESTIGATOR
Keimyung University Dongsan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keimyung University Dongsan Hospital
Daegu, Dalseogu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRUSTED
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.